Company intelligence / Profile preview

Glycology

Philadelphia, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Glycology, Inc. was a nutritional supplement company active in the mid-2000s that was publicly traded on the Pink Sheets. The company focused on the development and sale of health supplements but became inactive following regulatory and legal challenges, including an SEC investigation in 2008. In modern contexts, the name is also used for a skincare brand identity project and as a general academic term for glycobiology. It is not currently an active biotechnology company with a therapeutic pipeline.

Industry: Food & Nutrition

Beyond the preview

Go deeper on Glycology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycology.

Explore the full profile